期刊文献+

用重组腺病毒免疫方法制备伪狂犬病病毒gC蛋白单克隆抗体 被引量:1

Preparation of monoclonal antibodies against pseudorabies virus glycoprotein gC by immunization with recombinant adenovirus
下载PDF
导出
摘要 将表达伪狂犬病病毒(pseudorabies virus,PRV)gC基因的重组腺病毒经肌肉免疫BALB/c小鼠,测试了重组腺病毒免疫小鼠制备抗目的蛋白单克隆抗体的效果。ELISA分析表明,BALB/c小鼠接种重组腺病毒后能产生针对gC蛋白的特异性抗体。给BALB/c小鼠用大肠杆菌表达的gC融合蛋白MBP-gC-NC加强免疫后第3 d,取小鼠脾细胞与SP2/0小鼠骨髓瘤细胞在PEG4000作用下进行杂交融合,经筛选、克隆,获得了3株稳定分泌抗PRV gC蛋白单克隆抗体的杂交瘤细胞株,分别命名为1B4、1H4和2C8。单抗特性分析结果表明,1B4、2C8属IgG2a亚类,1H4属IgG1亚类;腹水抗体的ELISA效价为1∶2×10^5~1∶2×10^6;3株单抗都具有间接免疫荧光试验(IFA)和免疫印迹试验(Western-blotting)反应特性,能够特异地识别PRV gC蛋白。证实重组腺病毒免疫可用于制备目的蛋白单克隆抗体,为制备单抗提供了一种新的方法。 BALB/c mice were immunized intramuscularly with recombinant adenovirus expressing pseudorabies virus(PRV) glycoprotein gC gene to prepare monoclonal antibodies(McAbs) against PRV. ELISA results showed that anti-gC protein antibodies were able to be induced in immunized mice. On day 3 post-booster-immunization with the bacterially expressed gC protein MBP-gC-NC, the myeloma cell line SP2/0 was fused by PEG4000 with the splenocyte of mice after booster immunization. Then three McAbs, 1B4,1H4 and 2C8,were obtained and characterized with titers of 1∶2×10^5~1∶2×10^6in ascites. The Ig subclass of 1B4 and 2C8 belonged to IgG2a as contrast to IgG1 of 1H4. Immunofluorescence assay and Western blotting demonstrated that the McAhs were able to specifically react with PRV glycoprotein gC. The results indicated that recombinant adenovirus immunization was a novel and efficient way for preparing monoclonal antibodies against target protein.
出处 《中国兽医科学》 CAS CSCD 北大核心 2007年第8期684-689,共6页 Chinese Veterinary Science
关键词 重组腺病毒 伪狂犬病病毒 gC蛋白 单克隆抗体 recombinant adenovirus pseudorabies virus (PRV) gC protein monoclonal antibody
  • 相关文献

参考文献18

  • 1王凯,金宁一,鲁会军,韩松,徐一鸣,胡仲明.禽流感病毒H7亚型血凝素单克隆抗体的制备[J].中国预防兽医学报,2005,27(6):454-456. 被引量:2
  • 2谢文凯,钟平,潘卫庆,陈启宇,汪群斌,陆德如.重组恶性疟原虫DNA质粒免疫小鼠制备单克隆抗体[J].微生物学报,2000,40(4):389-393. 被引量:1
  • 3CHUNYA P,WATCHARA K,SUPA S,et al.Production of anti-dengue NS1 monoclonal antibodies by DNA immunization[J].J Virol Methods,2003,109(1):55-61.
  • 4YU X F,LIANG L H,SHE M,et al.Production of a monoclonal antibody against SARS-CoV spike protein with single intrasplenic immunization of plasmid DNA[J].Immunol Lett,2005,100(1):177-181.
  • 5KRASEMANN S,JURGENS K,BODEMER W.Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy[J].J Biotechnol,1999,73(2/3):119-129.
  • 6杨唐斌,曲丽娜.单克隆抗体研究新进展[J].航天医学与医学工程,2002,15(6):460-464. 被引量:3
  • 7倪翼,倪晶,汪晓华,郑秀娟,王缨,熊思东.基于基因免疫的抗HBVM蛋白单克隆抗体的制备[J].复旦学报(医学版),2004,31(2):202-205. 被引量:3
  • 8NIA T,HILDEGUND C J E.Adenoviruses as vaccine vectors[J].Mol Ther,2004,10(4):616-629.
  • 9汪家政 等.蛋白质技术手册[M].科学出版社,2001..
  • 10SEANGDEUN M,PANIDA K,WATCHARA K,et al.Production of polyclonal and monoclonal antibodies against CD54 molecules by intrasplenic immunization of plasmid DNA encoding CD54 protein[J].Immunol Lett,2001,76 (1):25-30.

二级参考文献57

  • 1梁荣,伊岚,李健强.小鼠IgG类单克隆抗体三种纯化方法的比较[J].细胞与分子免疫学杂志,1996,12(1):55-58. 被引量:13
  • 2[1]Mann MJ, Gibbons GH, Hutchinson H, et al. Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues[J]. Proc Natl Acad Sci USA,1999, 96(11):6411-6416.
  • 3[2]Rizzuto G, Cappelletti M, Maione D, et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation[J]. Proc Natl Acad Sci USA,1999, 96(11):6417-6422.
  • 4[3]Ulmer JB, DeWitt CM, Chastain M, et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants[J]. Vaccine 1999, 18(1-2):18~28.
  • 5[4]Singh M, Briones M, Ott G,et al. Cationic microparticles: a potent delivery system for DNA vaccines[J]. Proc Natl Acad Sci USA,2000,97(2):811-816.
  • 6[5]Briones M, Singh M, Ugozzoli M, et al. The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery[J]. Pharmaceutical Research,2001,18(5):709-722.
  • 7[6]Sin JI, Kim JJ, Zhang DH, et al. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4 T cell-mediated protective immunity against herpes simplex virus type 2 in vivo[J]. Human Gene Therapy,2001,12:1091-1102.
  • 8[7]Majlessi L, Bordenave G.Role of CD40 in a T cell-mediated negative regulation of Ig production[J]. J Immunol,2001,166(2): 841-7.
  • 9[8]Chen HW, Pan CH , Huan HW, et al. Suppression of immune response and protective immunity to a Japanese encephalitis virus DNA vaccine by coadministration of an IL-12- expressing plasmid[J]. J Immu, 2001,166(12):7419-7426.
  • 10[9]Chan K, Lee DJ, Schubert A,et al.The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA[J]. J Immunol,2001,166(5): 3061-6.

共引文献74

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部